MRK

Equity

Merck & Company, Inc.

Health Care · Drug Manufacturers - General

$120.18

+120.18 (+0.00%)

Open

N/A

Day Range

$117.87 - $120.23

52W Range

$73.31 - $125.14

Volume

3M

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Latest News

Moderna and Ross Stores Lead Stock Gainers on Wednesday

24/7 Wall St. 4 hours ago

Merck’s KEYTRUDA Combo Wins and Pipeline Shuffle Might Change The Case For Investing In Merck (MRK)

Simply Wall St. 12 hours ago

Most Retirees Overlook These Dow Dividend Stocks — They Pay More Than You’d Expect

24/7 Wall St. 1 day ago

Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead?

Zacks 1 day ago

Tempus AI, Merck Collaborate on AI-Driven Precision Medicine

MT Newswires 1 day ago

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ACAD ACADIA Pharmaceuticals Inc. $22.50 N/A - +0.00%
ABBV AbbVie Inc. $233.86 N/A 2.84% +0.00%
CRSP CRISPR Therapeutics AG $58.06 N/A - +0.00%
A Agilent Technologies, Inc. $119.04 N/A 0.84% +0.00%
ACB Aurora Cannabis Inc. $3.48 N/A - +0.00%
001540.KQ AHN-GOOK PHA $7,870.00 N/A 5.59% +0.00%
AHCO AdaptHealth Corp. $9.40 N/A - +0.00%
ABT Abbott Laboratories $114.12 N/A 2.10% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About Merck & Company, Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

www.merck.com →

🐂 Bull Score

Our proprietary rating measures dividend reliability based on 6 fundamental factors including payout sustainability, financial strength, and cash flow coverage.

F 25/100

Very Risky

Bull Score

~ Growing dividend (9 years) 10/25
+ Excellent profit margin (28%) 15/15
Limited data — score may change as more metrics become available

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

70

Safe

Based on 4 fundamental factors

+ 9 years of growth
+ Strong profit margins (28%)

Analysis Tools

Sign in for analysis tools

Share